⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL272737 | 0.70 | — | — | |
| SCHEMBL28617586 | 0.67 | — | — | |
| SCHEMBL28321174 | 0.67 | — | — | |
| Phosphine SCHEMBL8842535 | 0.67 | — | — | |
| SCHEMBL5694543 | 0.67 | — | — | |
| SCHEMBL6131269 | 0.67 | — | — | |
| SCHEMBL7877103 | 0.67 | — | — | |
| SCHEMBL27361 | 0.63 | — | — | |
| SCHEMBL3086186 | 0.63 | — | — | |
| SCHEMBL27921050 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0806411-B1 | Anti-viral compounds | LILLY CO ELI (US) | 2001-07-11 | — | — | EP | disclosed |
| EP-0806410-B1 | Anti-viral compounds | LILLY CO ELI (US) | 2001-07-11 | — | — | EP | disclosed |
| EP-0806409-B1 | Anti-viral compounds | LILLY CO ELI (US) | 2001-03-14 | — | — | EP | disclosed |
| EP-0811599-B1 | Anti-viral compounds | LILLY CO ELI (US) | 2001-03-07 | — | — | EP | disclosed |
| US-6180816-B1 | COMPOUNDS WHICH ABROGATE HEMAGGLUTININ-MEDIATED FUSION OF VIRUS-HOST MEMBRANES; TREATING INFLUENZA | ELI LILLY AND COMPANY | 2001-01-30 | — | — | US | disclosed |
| US-6180815-B1 | COMPOUNDS WHICH ABROGATE HEMAGGLUTININ-MEDIATED FUSION OF VIRUS-HOST MEMBRANES; TREATING INFLUENZA | ELI LILLY AND COMPANY | 2001-01-30 | — | — | US | disclosed |
| US-6175034-B1 | Anti-viral compounds | ELI LILLY AND COMPANY | 2001-01-16 | — | — | US | disclosed |
| EP-0806408-B1 | Anti-viral compounds | LILLY CO ELI (US) | 2000-12-13 | — | — | EP | disclosed |
| US-6156924-A | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 2000-12-05 | — | — | US | disclosed |
| US-6127422-A | INHIBITING AN ENVELOPE VIRUS SELECTED FROM THE GROUP CONSISTING OF INFLUENZA BOVINE DIARRHEAL, HEPATITIS C AND TICK BORNE ENCEPHALITIS VIRUS THAT UNDERGOES HEMAGGLUTININ MEDIATED FUSION WITH A HOST CELL; PHENANTHRENE ESTERS | ELI LILLY AND COMPANY (US) | 2000-10-03 | — | — | US | disclosed |
| WO-1997042155-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
| WO-1997041849-A1 | ANTI-VIRAL METHOD | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
| WO-1997041860-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
| WO-1997042156-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
| WO-1997041861-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
| EP-0806411-A2 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | disclosed |
| EP-0806203-A2 | Anti-viral compositions | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | disclosed |
| EP-0806410-A2 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | disclosed |
| EP-0806409-A1 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | disclosed |
| EP-0806408-A1 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | disclosed |